-The Economic Times MUMBAI: In a setback to Sanofi SA, the Bombay High Court has dismissed the plea filed by the French pharmaceutical major saying 'superior' packaging cannot be the argument for higher pricing of drugs. The court order also clarified that fixing the prices of drugs in the country will remain in the domain of the National Pharmaceutical Pricing Authority. In its argument, the pharmaceutical company had said it had relied...
More »SEARCH RESULT
Total Matching Records found : 157
SC’s Novartis judgement renews focus on accessible medicine
The recent Supreme Court judgment dismissing pharma giant Novartis’ claim for patent protections in India for its award-winning and prohibitively priced anti-leukemia drug Glivec has renewed the focus on accessibly-priced drugs – in particular the failure of the Indian public healthcare system and health policy to ensure affordable drugs for all. Studies show that as much as 70% of health spending in India comes from out-of-pocket payments, with 50-80% of...
More »No extension to RTE Act’s implementation deadline -Akshaya Mukul
-The Times of India NEW DELHI: HRD ministry has categorically ruled out extension of three-year deadline to states who failed to create the necessary infrastructure to implement the Right to Education (RTE) Act, whose deadline expired on March 31. Acceding to the extension request would have meant amending the RTE Act. But at the end of 61st meeting of the Central Advisory Board on Education (CABE) HRD minister M M Pallam Raju...
More »Artful claims can’t decide patent law: court-J Venkatesan
-The Hindu The law of patent in India could not be developed on the artful drafting of claims by companies rather than on the intrinsic worth of invention, the Supreme Court has ruled, rejecting Novartis' claim for patent for its cancer drug. A Bench of Justices Aftab Alam and Ranjana Desai said, "We certainly do not wish the law of patent... to develop on the lines where there may be a vast...
More »Aakash is no silver bullet-Akshat Rathi
-The Hindu The government needs to open its eyes and realise that the technological utopia it envisions in the low-cost tablet is no cure for poor education, poverty or inequality The last few days have brought the Aakash tablet back into the media limelight. Last Friday, Human Resource Development (HRD) Minister M.M. Pallam Raju said that troubles with the manufacturer could doom the project. But the next day, former HRD Minister Kapil...
More »
